Ricardo Spielberger

Ricardo Spielberger, M.D.

  • Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation

Ricardo Spielberger, M.D.

Locations

Duarte

1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673

Degrees

  • 1978-1985, Universidad Central de Venezuela, "Luis Razetti" Medical School, Caracas-Venezuela

Fellowship

  • 1993-1994, Bone Marrow Transplantation, City of Hope, Duarte, CA
  • 1991-1993, Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois

Residency

  • 1988-1990, Internal Medicine, Parkland Memorial Hospital, University of Texas, Southwestern Medical School, Dallas, Texas

Internship

  • 1987-1988, Internal Medicine, Parkland Memorial Hospital, University of Texas, Southwestern Medical School, Dallas, Texas
  • 1994, American Society of Hematology
  • 1993, 2014, American Society of Medical Oncology
  • 1990, American Board of Internal Medicine
  • Stein AS, O'Donnell MR, Synold TW, Dagis AC, Tsirunyan A, Nademanee AP, Parker PM, Pullarkat VA, Snyder OS, Spielberger RT, Wong JY, Alvarnas JC, Thomas SH, Forman SJ. Phase-2 trial of an intensified condition regimen for allogeneic heatopoietic cell transplant for poor-risk leukemia. Bone Marrow Transplant. 2011 Sep;46(9): 1256-62. DOI: 10.1038/bmt.2010.295. Epub 2010 Dec 13. PMID: 21151180
  • Sahebi F, Frankel PH, Farol L, Krishnan AY, Cai JL, Somlo G, Thomas SH, Reburiano E, Popplewell LL, Parker PM, Spielberger RT, Kogut NM, Karanes C, Htut M, Ruel C, Duarte L, Murata-Collins JL, Forman SJ. Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant. 2012 Mar;18(3):486-92. Epub 2011 Dec 22. PMID: 22198542.
  • Nguyen DT, Shayani S, Palmer J, Dagis A, Forman SJ, Epstein J, Spielberqer R. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation. Support Care Cancer. 2015 Nov;23(11 ):3141-7. DOI: 10.1007/s00520-015-2688-7. Epub 2015 Mar 21.
  • Stiff PJ, Leinonen M, Kullenberg T, Rudebeck M, de Chateau M, Spielberger R. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis. Biol Blood Marrow Transplant. 2015 Aug 22. pii: S1083-8791(15)00547-9. DOI:10.1016/j.bbmt.2015.08.018. [Epub ahead of print] PMID:26303102
  • Wong JY, Stein A, Palmer JM, Liu A, O'Donnell M, Schultheiss T, Radany E, Snyder DS, Tsai N, Parker P, Farol L, Spielberger R, Sahebi F, Murata-Collins J, Senitzer D, Forman S. Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT). International Journal of Radiation Oncology• Biology• Physics , Sept 1, 2014, Volume 90 , Issue 1 , S681
  • Nguyen DT, Shayani S, Palmer J, Dagis A, Forman SJ, Epstein J, Spielberger R. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation. Support Care Cancer. 2015 Nov;23( 11 ):3141-7. doi: 10 .1007/s00520-015-2688-7. PM I D:25 791390
  • Stiff PJ, Leinonen M, Kullenberg T, Rudebeck M, de Chateau M, Spielberger R. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis. Biol Blood Marrow Transplant. 2016 Jan;22(1 ):164-9. DOI: 10.1016/j.bbmt.2015.08.018. PMID:26303102
  • Stein A, Palmer J, Tsai NC, Al Malki MM, Aldoss I, Ali H, Aribi A, Farol L, Karanes C, Khaled S, Liu A, O'Donnell M, Parker P, Pawlowska A, Pullarkat V, Radany E, Rosenthal J, Sahebi F, Salhotra A, Sanchez JF, Schultheiss T, Spielberger R, Thomas SH, Snyder D, Nakamura R, Marcucci G, Forman SJ, Wong J. Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia. Biol Blood Marrow Transplant. 2017 Jan 10. pii: S1083-8791(17)30192-1. DOI:10.1016/j.bbmt.2017.01.067. [Epub ahead of print] PMID:28087456
  • Krishnan AY, Palmer J, Nademanee AP, Chen R, Popplewell LL, Tsai NC, Sanchez JF, Simpson J, Spielberger R, Yamauchi D, Forman SJ. Phase II Study of Yttrium-90 lbritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: the Role of Histology. Biol Blood Marrow Transplant. 2017 Mar 3. pii: S1083-8791(17)30312-9. DOI: 10.1016/j.bbmt.2017.03.004. [Epub ahead of  print]PMID:28267593
  • Medical Board of California
  • Venezuelan College of Physicians
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Bone Marrow Transplantation
Back To Top